Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

RWJ-26819: Non-steroidal progestin agonist from R.W. Johnson

July 12, 1996

U.K. and Canadian approval sought for Alora

July 12, 1996

New formulation of rhGH from Alkermes and Genentech

July 12, 1996

KGR-1380: A novel glycation inhibitor

July 12, 1996

Aldose reductase inhibitors described by Grelan

July 12, 1996

Optro enters U.S./Canadian phase II trials

July 12, 1996

Pharmacia & Upjohn terminates Hemopure codevelopment agreement

July 12, 1996

Results of fat accumulation/PAI-1 levels relationship study disclosed

July 12, 1996

Aryloxypropanolamine beta3-adrenoceptor agnoists from Bristol-Myers Squibb

July 12, 1996

(+)-Sch-58053: Schering-Plough's cholesterol absorption inhibitor

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 21, 2025.
ADPD 2025: Novel treatment modalities in neurodegenerative disorders
BioWorld Science
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...
Post-Pfizer dropout, Lilly Achieves GLP-1 win in phase III
BioWorld
Days after Pfizer Inc. pulled the plug on its oral GLP-1 candidate danuglipron, Eli Lilly and Co. aired positive top-line data from the phase III trial called...
Many US tariffs paused, pharma warned, EU put on notice
BioWorld
The on-again, off-again U.S. tariffs are off again, at least for now, for more than 75 countries that have reached out to the Trump administration to negotiate...